Storia in 1 fonti

LifeSci Capital Reaffirms Their Buy Rating on Upstream Bio, Inc. (UPB)

LifeSci Capital analyst Kate Dellorusso maintained a Buy rating on Upstream Bio, Inc. today and set a price target of $42.00.Claim 55% Off TipRa...

Raccontata da